KRT17 and neoplasm: C7 is upregulated in metastatic sample compared to primary tumor, while KRT17, CLEC2A, S1007A, KRTDAP, WFDC5, KRT6B, S100A7, KRT14, and PVRL4 are downregulated (or upregulated in primary tumor compared to metastatic sample).